FDA Inspection 716890 — Boiron Inc.

Boiron Inc. — FEI 2510831

The FDA completed an inspection of Boiron Inc. on March 18, 2011 in Newtown Square, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newtown Square, PA (United States)